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Abstract
A chronic proinflammatory state precedes pathological change in arterial endothelial cells located within
regions of susceptibility to atherosclerosis. Thepotential contributions of regulatory microRNAs to this
disequilibrium were investigated by artery site-specific profiling in normal adult swine. Expression of
endothelial microRNA10a (miR-10a) was lower in the athero-susceptible regions of the inner aortic arch and
aorto-renal branches than elsewhere. Expression of Homeobox A1 (HOXA1), a known miR-10a target, was
up-regulated in the same locations. Endothelial transcriptome microarray analysis of miR-10a knockdown in
cultured human aortic endothelial cells (HAEC) identified IκB/NF-κB–mediated inflammation as the top
category of up-regulated biological processes. Phosphorylation of IκBα, a prerequisite for IκBα proteolysis and
NF-κB activation, was significantly up-regulated in miR-10a knockdown HAEC and was accompanied by
increased nuclear expression of NF-κB p65. The inflammatory biomarkers monocyte chemotactic protein 1
(MCP-1), IL-6, IL-8, vascular cell adhesion molecule 1 (VCAM-1), and E-selectin were elevated following
miR-10a knockdown. Conversely, knockin of miR- 10a (a conservative 25-fold increase) inhibited the basal
expression of VCAM-1 and E-selectin in HAEC. Two key regulators of IκBα degradation— mitogen-activated
kinase kinase kinase 7 (MAP3K7; TAK1) and β-transducin repeat-containing gene (βTRC)—contain a
highly conserved miR-10a binding site in the 3′ UTR. Bothmolecules were up-regulated by miR-10a
knockdown and suppressed by miR-10a knockin, and evidence of direct miR-10a binding to the 3′ UTRwas
demonstrated by luciferase assay. Comparative expression studies of endothelium located in athero-
susceptible aortic arch and athero-protected descending thoracic aorta identified significantly up-regulated
MAP3K7, βTRC, phopho-IκBα, and nuclear p65 expression suggesting that the differential expression of
miR-10a contributes to the regulation of proinflammatory endothelial phenotypes in athero-susceptible
regions in vivo.
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MicroRNA-10a regulation of proinﬂammatory
phenotype in athero-susceptible endothelium
in vivo and in vitro
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A chronic proinﬂammatory state precedes pathological change in
arterial endothelial cells located within regions of susceptibility to
atherosclerosis. Thepotential contributionsof regulatorymicroRNAs
to this disequilibrium were investigated by artery site-speciﬁc pro-
ﬁling in normal adult swine. Expression of endothelial microRNA10a
(miR-10a) was lower in the athero-susceptible regions of the inner
aortic arch and aorto-renal branches than elsewhere. Expression of
Homeobox A1 (HOXA1), a knownmiR-10a target, was up-regulated
in the same locations. Endothelial transcriptomemicroarray analysis
of miR-10a knockdown in cultured human aortic endothelial cells
(HAEC) identiﬁed IκB/NF-κB–mediated inﬂammation as the top cat-
egory of up-regulated biological processes. Phosphorylation of IκBα,
a prerequisite for IκBα proteolysis and NF-κB activation, was signif-
icantly up-regulated in miR-10a knockdown HAEC and was accom-
panied by increased nuclear expression of NF-κB p65. The inﬂamma-
tory biomarkers monocyte chemotactic protein 1 (MCP-1), IL-6, IL-8,
vascular cell adhesionmolecule 1 (VCAM-1), and E-selectin were ele-
vated following miR-10a knockdown. Conversely, knockin of miR-
10a (a conservative 25-fold increase) inhibited the basal expression
of VCAM-1 and E-selectin in HAEC. Two key regulators of IκBα deg-
radation—mitogen-activated kinase kinase kinase 7 (MAP3K7; TAK1)
and β-transducin repeat-containing gene (βTRC)—contain a highly
conservedmiR-10a binding site in the 3′UTR. Bothmoleculeswere
up-regulated by miR-10a knockdown and suppressed by miR-10a
knockin, and evidence of direct miR-10a binding to the 3′UTRwas
demonstrated by luciferase assay. Comparative expression stud-
ies of endothelium located in athero-susceptible aortic arch and
athero-protected descending thoracic aorta identiﬁed signiﬁ-
cantly up-regulated MAP3K7, βTRC, phopho-IκBα, and nuclear
p65 expression suggesting that the differential expression of
miR-10a contributes to the regulation of proinﬂammatory endo-
thelial phenotypes in athero-susceptible regions in vivo.
β-transducing repeat-containing gene | hemodynamics | mitogen-activated
kinase kinase kinase 7 | NF-κB
Atherosclerosis, a local chronic inﬂammatory disease of arter-ies, originates and develops preferentially at sites of curvature,
branching, and bifurcation in large elastic andmuscular distributing
arteries where complex hemodynamic conditions are prominent
(1, 2). The endothelium of prelesional athero-susceptible regions
is subtly different from that located at nearby athero-resistant sites;
differential transcriptional, translational, and posttranslational phe-
notypes have been identiﬁed, including sensitization of inﬂammatory
regulators, coagulation, redox balance, endoplasmic reticulum stress,
and lipid balance (3–9). Complementary experiments using cultured
endothelial cells subjected to various arterial ﬂow waveforms mod-
eled fromregionsofathero-protectionand susceptibility showseveral
differentially expressed transcription factors that regulate down-
stream pathways important in endothelial function relevant to ath-
erogenesis. Notably, athero-protective Krüppel-like factors promote
an antiinﬂammatory and anticoagulant endothelial phenotype,
whereas activator protein-1 and NF-κB induce a proinﬂammatory
and procoagulant endothelium (10–13). Additional levels of regu-
latory control by smallRNAs are nowemerging in the cardiovascular
system(14, 15).MicroRNAs (miRNAs), highly conservednoncoding
small RNAs of 19–26 nucleotides, are key posttranscriptional gene
regulators that contribute to the maintenance of differentiated cell
phenotypes (16); however, the identities of miRNAs mediating en-
dothelial phenotypes in relation to athero-susceptibility in vivo
are unknown.
Mammalian miRNAs usually bind to the 3′ UTR of target
mRNAs, promoting mRNA degradation and/or inhibiting trans-
lation of the protein-coding genes (16). Evolutionarily conserved
Watson–Crick pairing between cognate mRNA 3′ UTR and
miRNA 5′ regions centered on seed nucleotides (nucleotides 2–7)
primarily determines miRNA target selection (17). Emerging evi-
dence suggests that individual miRNAs ﬁne-tune the synthesis of
many genes and that miRNA-mediated proteomes typically are
mirrored by transcriptomes (18, 19). Given the widespread scope
but modest repression of transcriptomes/proteomes by individual
miRNAs, it is proposed that phenotypical consequences can be
achieved by coordinated actions on multiple targets by single
miRNAs or that multiple miRNAs have an integrated regulatory
effect on key pathways (20, 21). Disruption of the tightly regulated
spatial and temporal expression of miRNAs is implicated in human
diseases such as cancer, infectious diseases, and cardiovascular
diseases. In the vascular system, endothelial miRNA-mediated an-
giogenesis has been demonstrated by mutation or disruption of
Dicer (22, 23), the rate-limiting enzyme involved in miRNA matu-
ration, and individual miRNAs associated with proangiogenic or
antiangiogenic endothelial phenotypes have been identiﬁed (24,
25). Furthermore, endothelial miR-126 has been shown to suppress
vascular cell adhesion molecule 1 (VCAM-1) expression in vitro,
implicating miRNAs in the control of endothelial responses to
vascular perturbation (26).
We report differential endothelial miRNA expression in vivo at
athero-susceptible and athero-protected regions of aorta and renal
arteries in normal adult swine in the absence of known systemic risk
factors. Signiﬁcant low endothelial expression of microRNA10a
(miR-10a) detected in regions of athero-susceptibility was investi-
gated by a combination of genomic proﬁling, microRNA manipu-
lations, and molecular analyses in freshly isolated arterial endo-
thelium and in cultured cells.
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Results
Endothelial cells were harvested from swine aortas and aorto-
renal bifurcations from (i) the inner curvature of the aortic arch
(AA) and nearby descending thoracic aorta (DT), and (ii) the
cranial wall and caudal wall of the aorto-renal branches and the
distal renal artery (Fig. 1).
Low Expression of Endothelial miR-10a/b at Athero-Susceptible Arterial
Sites inVivo.Differential expression analysis of multispeciesmiRNA
microarrays identiﬁed seven down-regulated and twenty-seven up-
regulated miRNAs in athero-susceptible AA endothelia (Fig. S1)
when compared with athero-protected dorsal DT. The lowest rel-
ative expression was that of miR-10a/b. Real-time PCR demon-
strated 71 ± 13% and 83 ± 15% lower expression of endothelial
miR-10a and miR-10b, respectively, in the athero-susceptible AA
(Fig. 2 A and B). A high incidence of human atherosclerosis at the
cranial wall of the renal branch and low incidence in distal renal
artery has been reported, whereas the caudal site of the renal
branches exhibits modest susceptibility (27). Endothelial miR-10a
and miR-10b expression were 63 ± 14% and 48 ± 25% lower, re-
spectively, at the athero-susceptible cranial wall of the renal branches
than at the protected distal renal artery (Figs. 2 C and D), whereas
miR-10a expression at the caudal wall of the aorto-renal bifurcation
was between the levels of the other two sites (Fig. 2C). The data
demonstrate site-speciﬁc low expression of endothelial miR-10a/b in
regions susceptible to atherosclerosis in vivo.
Endothelial Speciﬁcity and Relative Expression of miR-10a/b. Locked
nucleic acid (LNA)-FISH (28) of frozen sections of freshly iso-
lated swine aorta showed miR-10a/b expression largely conﬁned
to the endothelium with stronger miR-10a staining than miR-10b
staining (Fig. 3A and Fig. S2). The ratio of miR-10a/miR-10b
expression in freshly isolated swine aortic endothelium and in
cultured human aortic endothelial cells (HAEC), determined by
quantitative real-time-PCR, showed endothelial miR-10a ex-
pression to be considerably higher than miR-10b (>10-fold and
38-fold respectively; Fig. 3B) in agreement with the FISH
images. Low expression of miR-10a therefore was likely to be of
greater consequence, and this isoform was investigated further.
Validation of miR-10a Regulation of a Known Target Transcription
Factor Homeobox A1. Homeobox A1 (HOXA1) is an experimentally
validateddownstream target ofmiR-10a, as shownby directHOXA1
3′ UTR-dependent suppression during megakaryocytopoiesis (29).
Expression of HOXA1 therefore was examined in miR-10a knock-
downHAEC in vitro and then the investigation was extended in vivo
to swine endothelia at arterial sites exhibiting expression of different
levels of miR-10a. In HAEC, miR-10a inhibitors suppressed en-
dogenous expression by 81 ± 5% (Fig. S3A) while signiﬁcantly up-
regulating HOXA1 expression at the transcript and protein levels
(Fig. S3B). The degree of inhibition of miR-10a obtained in vitro is
comparable to the relatively lowexpressionnoted inAA in vivo (29%
ofDT).Similarly,HOXA1wasexpressedat signiﬁcantlyhigher levels
in athero-susceptible AA (Fig. S3C) and at the cranial wall of aorto-
renal bifurcations (Fig. S3D) in a reciprocal relationship to the down-
regulation of miR-10a in these regions and consistent with miR-10a
modulation of HOXA1 mRNA.
Activation of NF-κB Signal Transduction in miR-10a Knockdown HAEC.
The effects of miR-10a knockdown on the endothelial transcriptome
were determined in cultured HAEC by whole-genome microarray
analyses. Differential transcript expression proﬁles identiﬁed 1,081
up-regulated and 794 down-regulated genes in miR-10a knockdown
cells compared with control cells. The widespread impact on the en-
dothelial transcriptome is consistent with recent studies demonstrat-
ing thata singlemiRNAcanﬁne-tune theexpressionofmanygenesby
direct or indirect effects (19, 20). Gene set enrichment analysis
(GSEA), a knowledge-based approach for interpreting genome-wide
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Fig. 1. Arterial regions of endothelial isolation. Endothelial cells were
scraped gently from the inner curvature of AA, the DT, and the distal renal
artery (A and B) as well as from the caudal and cranial regions of the aorto-
renal bifurcations (C and D). (Scale bars, 1 cm.)
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Fig. 2. Low expression of endothelial miR-10a/b at athero-susceptible arte-
rial sites. (A and B) Suppression of endothelial miR-10a and miR-10b at athero-
susceptible AA compared with DT (n = 10). (C and D) Suppression of endothelial
miR-10aandmiR-10batathero-susceptible cranial and caudalwalls of the aorto-
renal bifurcations compared with distal renal artery (n = 3 paired samples; each
paired sample was pooled from the same four animals). Data represent mean ±
SEM. *P < 0.05.
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expression proﬁles (30), identiﬁed IκB/NF-κB–mediated inﬂamma-
tion as the top biological processes up-regulated in miR-10a knock-
down cells (Table 1). In nonactivated endothelial cells, NF-κB is
bound to IκBs and is retained in the cytoplasm. Activation of NF-
κB (nuclear translocation of p65) is contingent upon phosphory-
lation, polyubiquitination, and subsequent proteolysis of IκBs. In
agreement with the GSEA analysis, nonphosphorylated IκBα
was signiﬁcantly decreased in miR-10a knockdown cells (Fig. 4A),
whereas nuclear p65 increased at the expense of cytoplasmic p65
(Fig. 4 B and C). Conﬁrmation of NF-κB activation in miR-10a
knockdown HAEC was provided by signiﬁcant up-regulation of
the proinﬂammatory biomarkers monocyte chemotactic protein
1 (MCP-1), IL-6, IL-8, VCAM-1, and E-selectin (Fig. 4D). En-
dogenous phosphorylation of IκBα, a prerequisite for IκBα pro-
teolysis, was not detectable, probably because of high turn-
over; however, when stimulated by a 10-min exposure to TNFα,
phospho-IκBα was signiﬁcantly elevated by miR-10a knockdown
compared with control cells exposed to the cytokine (Fig. 4E).
Therefore, inhibition of endogenousmiR-10a led to changes in the
endothelial transcriptome that promoted NF-κB activation, in-
creased IκBα degradation, and augmented p65 nuclear trans-
location, resulting in up-regulation of inﬂammatory biomarkers.
Suppressed Endothelial miR-10a Enhances Expression of MAP Kinase
Kinase Kinase 7and β-Transducin Repeat-Containing Gene in Vitro. To
investigate the molecular mechanisms underlying miR-10a regula-
tion of proinﬂammatory molecules, genes in the canonical NF-κB
pathway (Fig. S4) were interrogated with miR-10a putative down-
stream targets generated by TargetScan 5.1 that considers evolu-
tionary conservation of miR seed sites (31). The in silico analyses
identiﬁed two molecules: the mitogen-activated protein kinase ki-
nase kinase 7 (MAP3K7; also known as TAK1) gene, and the
β-transducin repeat-containing gene (βTRC; also known as
β-TrCP). Both promote proteasomal degradation of IκBα and p65
nuclear translocation (Fig. 5) and contain evolutionarily conserved
miR-10a binding sites in the 3′ UTRs (Fig. 6 A and B). MAP3K7
protein directly phosphorylates and activates IκB kinase β (IKKβ),
stimulating phosphorylation of IκBs. βTRC recognizes phosphor-
ylated IκBs and mediates phosphorylation-dependent ubiquitina-
tion leading to IκB proteolysis. Knockdown of endothelial miR-10a
in HAEC signiﬁcantly up-regulated MAP3K7 and βTRC expres-
sion as demonstrated by real-time PCR andWestern blot (Fig. 6 C
andD). Theup-regulation ofMAP3K7and βTRCbyknockdownof
miR-10a, predicted by in silico analyses, is consistent with the acti-
vationofNF-κBsignal transduction inmiR-10aknockdownHAEC.
miR-10a Inhibits MAP3K7 and βTRC Through 3′ UTR Binding. A dual-
luciferase reporter assay demonstrated a direct interaction of
miR-10a and the 3′UTRsequences ofMAP3K7 and βTRC.Three
tandem repeats of the predicted miR-10a recognition elements
present in MAP3K7 or βTRC 3′ UTR were inserted into the 3′
UTR of Renilla luciferase (Fig. S5). Intracellular delivery of miR-
10a biomimetics signiﬁcantly repressed the Renilla luciferase ac-
Table 1. Enriched GO biological processes up-regulated in miR-10a knockdown cells, identiﬁed
by GSEA at 25% false discovery rate (FDR)
GO biological process Process gene set FDR
GO:0043123 Positive regulation of I-κB kinase/NF-κB cascade 0.033
GO:0043122 Regulation of I-κB kinase/NF-κB cascade 0.039
GO:0007249 I-κB kinase/NF-κB cascade 0.058
GO:0006955 Immune response 0.173
GO:0006954 Inﬂammatory response 0.198
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Fig. 4. Activation of NF-κB signal transduction in miR-10a knockdown (KD)
HAEC. (A) Suppression of total IκBα inmiR-10a knockdownHAECs (n = 3). β-actin
was used as an internal control (Ctl). (B and C) Increased nuclear expression and
decreased cytoplasmic expression of NF-κB p65 in miR-10a knockdown cells.
Nuclear (n = 4) and cytoplasmic (n = 3) expression of p65 was normalized to
laminB1andβ-actin, respectively. (D)Up-regulationofE-selectin (E-SEL),VCAM-1,
IL-6, IL-8, andMCP-1 in miR-10a knockdown HAEC. mRNAs of the inﬂammatory
biomarkers were normalized to ubiquitin expression (n = 6 or 7). (E) Increased
phosphorylated IκBα in miR-10a knockdown cells (n = 3). IκBα phosphorylation
was stimulated by 5 ng/mL TNF-α for 10 min, and phospho-IκBα expression was
normalized to total IκBα. Data represent mean ± SEM. *P < 0.05.
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tivity, by 25% and 55%, respectively, in HEK293 cells expressing
MAP3K7 3′ UTR- or βTRC 3′ UTR-containing luciferase tran-
scripts (Fig. 6E). Renilla luciferase inserted with putative let-7b
binding sites, cloned from LIN-24 3′ UTR, was not responsive to
miR-10a knockin (Fig. 6E). It is notable that insertion of the miR-
10a recognition element cloned from βTRC led to higher lucif-
erase inhibition than seen with MAP3K7, even though both
sequences contain an identical evolutionarily conserved binding
site for the miR-10a seed region; this ﬁnding indicates that addi-
tional structural features of these miR-10a recognition elements
may inﬂuence the miR-10a–mediated regulation (32). Consistent
with this observation, inhibition of endogenous endothelial miR-
10a led to higher regulation of βTRC than MAP3K7 at the tran-
scriptional and translational levels (Fig. 6C).
Overexpression of Endothelial miR-10a Down-Regulates Inﬂamma-
tory Molecules in Vitro. Intracellular delivery of biomimetic miRs
(typically at 25–50 nM) results in overexpression by several thou-
sand-fold. We titrated miR-10a overexpression to a lower, more
physiologically relevant range (∼25-fold at 0.01 nM; Fig. S6A) in
cultured HAEC. This level of miR-10a up-regulation signiﬁcantly
inhibited basal transcript expression of MAP3K7, βTRC, and the
downstream proinﬂammatory markers E-selectin and VCAM-1
(Fig. S6B).
MAP3K7, βTRC, IκBα, and p65 in Athero-Susceptible AA in Vivo. Fi-
nally, to investigate evidence for an in vivo equivalent of the in
vitro knockdown and knockin experiments, endothelial MAP3K7
and βTRC expression were measured in athero-susceptible swine
AA, a site of suppressed expression of miR-10a. Both genes were
signiﬁcantly up-regulated in AA compared with DT (Fig. 7).
Furthermore, in AA endothelium, steady-state phospho-IκB was
increased, but IκBα expression declined, indicating increased
proteolysis of IκBα with a signiﬁcant elevation of nuclear p65 in
the same athero-susceptible region (Fig. 7). These in vivo data are
consistent with a steady-state reciprocal relationship between
miR-10a suppression and proinﬂammatory endothelial pheno-
type at athero-susceptible sites.
Discussion
Despite exposure of the entire arterial tree to systemic risk factors,
atherosclerosis preferentially develops in predisposed arterial re-
gions of ﬂow disturbance. In the prelesion stage of normal arteries,
athero-susceptible regions exhibit low-grade chronic inﬂammation
in the intimawhere enhancedNF-κBactivity in endothelial cellsmay
inﬂuence the regional sensitivity foratherogenesis (7, 33). In amouse
model, increased phosphorylation of IκBα in lesion-susceptible
regions is consistent with preferential activation of endothelial
NF-κB signaling under the systemic stimuli of hypercholesterol-
emia and lipopolysaccharide (7). Regional expression of kinases,
small GTPases, and transcription factors is proposed to account,
in part, for the predisposition of NF-κB activation in the lesion-
prone regions (3, 6, 10, 34, 35). Here we addressed miRNA regu-
lation by directly accessing athero-susceptible and athero-protected
endothelial regional miRNA proﬁles to determine steady-state
miRNAexpression invivo. In silicoanalysesand invitro interventions
demonstrated that miR-10a suppression in athero-susceptible re-
gions probably contributes to endothelial proinﬂammatory NF-κB
signaling in vivo.
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Fig. 6. miR-10a negatively regulates MAP3K7 and βTRC through their 3′ UTR
binding site. (A and B) Evolutionarily conserved putative miR-10a binding site
within the 3′ UTR of MAP3K7 and βTRC. (C and D) Increased expression of
MAP3K7 in miR-10a knockdown HAEC. Gene (n = 7–10) and protein (n = 3)
expressions were normalized to GAPDH and β-actin, respectively. (E) Reduced
luciferase activity in HEK293 cells overexpressing miR-10a following insertion
of miR-10a binding elements cloned from MAP3K7 and βTRC 3′ UTRs. Data
represent mean ± SEM. ns, not signiﬁcant. *P < 0.05.
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Two phases of the study used unbiased genomics, ﬁrst to identify
regional miRNA expression in arterial endothelium and second to
determine the target pathways most affected by miR-10a knock-
down inHAEC. From this study emerged in silico putativemiR-10a
targets that are inﬂuential in the regulation of IkB. We prioritized
miR-10 for study because it is the most highly modulated miRNA
identiﬁed. When the results suggested by the in vitro HAEC
manipulations were probed in vivo, a pattern consistent with miR-
10a regulation of proinﬂammatory phenotype emerged.
The interplay of miRNAs with their targets is complex, and it is
unlikely that any singlemiRNAor its targets are entirely responsible
for spatially related differences in endothelial phenotype in arteries.
As reported in Fig. S1, transcript proﬁling identiﬁed the differential
expression of several other miRNAs in swine athero-susceptible
regions; these miRNAs also are under investigation and may relate
to the current ﬁndings. In that context, Zhou et al. (36) recently
identiﬁed four miRNAs in inﬂammatory epithelial cells that are
directly activated by the binding of p65 to their promoter regions:
miR-21, miR-23b, miR-30b, and miR-125b. In our global proﬁling,
all four miRNAs are modestly up-regulated in AA endothelial cells
(Fig. S1), a site of suppressed miR-10a and elevated p65 nuclear
expression.Thesedatanot only support adifferent equilibriumstate
ofNF-κB activation in the athero-protective and athero-susceptible
endothelial phenotypes in vivo but also support a putative indirect
role of other miRNAs in endothelial miR-10a regulation.
Without preconceived expectations of NF-κB pathway regula-
tion by miR-10a, GSEA identiﬁed up-regulated IκB/NF-κB sig-
naling pathways and inﬂammatory response in miR-10a knock-
down HAEC, and the mechanistic link was predicted when genes
that direct or mediate the NF-κB canonical pathways were cross-
referenced with the miR-10a putative downstream targets gen-
erated in silico by TargetScan 5.1. Evolutionarily conserved miR-
10a binding sites were identiﬁed in the IκB/NF-κB regulators
MAP3K7 and βTRC. Both genes have a well-established role in
activating NF-κB signal transduction by provoking IκBdegradation.
MAP3K7 activates IKKβ that phosphorylates IκBs in response to
inﬂammatory stimuli (37). βTRC constitutes the substrate recogni-
tion subunit of SCFb-TrCPE3 ubiquitin ligase that ubiquitinates the
phosphorylated IκBs (38). Phosphorylation and subsequent ubiq-
uitination of IκBs leads to a 26S proteome-mediated proteolysis of
IκBs and consequent nuclear translocation of active NF-κB dimers.
Inhibition of eitherMAP3K7or βTRC increases the total expression
of IκBand impairsNF-κBactivation.OurdatademonstratemiR-10a
as a posttranscriptional regulator of the IκB/NF-κB signaling path-
way by suppressing MAP3K7 and βTRC. It has been suggested that
coordinated actiononmultiple target genes bya singlemiRNAcould
provide a powerful mechanism by which a singlemiRNA can impact
a complex regulatory network and ultimately the physiological pro-
cess or disease (21).
Members of the miR-10 family are regulators of HOX genes
during development and are deregulated in several cancer forms
(39). Garzon et al. (29) reported the inhibition of miR-10a during
megakaryocytic differentiation and identiﬁed its direct downstream
target HOXA1 (used for site-speciﬁc validation in our study). miR-
10a knockdown in HAEC led to a widespread impact on the tran-
scriptome (∼1,900 genes) but did not identify the HOX-mediated
gene network as one of the top regulated biological processes in the
present study. The global and moderate inﬂuence of miR-10a on
endothelial mRNA expression is consistent with recent transcrip-
tional analyses in individual RNA knockin/knockdown HeLa cells
(19, 20) and is in agreement with the emerging view that a single
miRNA represses numerous genes that mediate a wide variety of
biological and molecular functions (20). Recently, miR-10a regu-
lation of ribosomal proteins via a HOX-independent mechanism
was reported (40).
In the cardiovascular system miRNAs are expressed in a tempo-
ral-spatial fashion. Emerging studies show them to be important
modulators of cardiovascular development (41) and angiogenesis
(25), and aberrant miRNA expression is associated with cardiac
arrhythmia, cardiachypertrophy, andarterial stenosis (42).They are
implicated in arterial hyperplasia through regulation of pro-
liferation and phenotype switching of vascular smooth muscle cells
(43). Two recent studies in cultured endothelial cells have linked
miR126 to TNF-induced endothelial VCAM-1 expression (26) and
miR-31 and miR17-3p to E-selectin and intercellular adhesion
molecule 1 expression, respectively (44). However, we did not
identify differential expression of these miRNAs in atherosuscep-
tible sites in vivo. A recent report (45) included miR-10a (among
others) as a ﬂow-responsive miR in vitro which may be related to a
hemodynamic mechanism underlying our in vivo ﬁndings. By iden-
tifying miR-10a as a posttranscriptional regulator of NF-κB activa-
tion throughMAP3K7andβTRC,our study linksmiRNAregulation
in arterial endothelium with endothelial athero-susceptibility/pro-
tection signatures in vivo. Furthermore, because inhibition of
IκBα reduces atherosclerotic plaque formation in apoE−/−mice (46),
noncoding miRNAs may be suitable therapeutic targets in vascu-
lar inﬂammation.
Methods
Expanded methods are provided in SI Methods.
Swine Sample Collection. Arterial tissues were obtained from adult pigs
(6-mo-old; ∼250 lb) immediately after pigs were killed at a local abattoir
(Hatﬁeld Industries). Endothelial cells were freshly harvested by gentle
scraping of regions described in Fig. 1. Endothelial cell purity assessed by
antibody staining for endothelium, smooth muscle cells, and leukocytes
ranged between 96–100% (3, 9) and was not signiﬁcantly different for AA
and DT regions.
MicroRNA Microarray. Endothelial cells were collected from the athero-
susceptible AA and athero-protected DT of 35 swine. For each arterial site,
endothelial samples from ﬁve animals were pooled to provide seven bi-
ological replicates for microarray experiments. miRNAs were isolated using
the mirVana isolation kit (Ambion) and proﬁled using NCode multispecies
miRNA microarrays (Invitrogen). The complete Minimum Information about
a Microarray Experiment (MIAME)-compliant annotated study has been
deposited in the public repository ArrayExpress (accession number E-CBIL-46).
Detailed MIAME-compliant annotation and data for this study also are
available for query at www.cbil.upenn.edu/RAD.
MicroRNA and cDNA Quantitative Real-Time PCR. Expression of selected miR-
NAs was quantiﬁed by two-step quantitative real-time PCR (Applied Bio-
systems) and normalized to endogenous small nuclear U6B RNA. cDNA was
quantiﬁed using LightCycler FastStart DNAMaster SYBR Green I or Masterplus
SYBR Green I (Roche). PCR primers for genes of interest are listed in Table S1.
A
0
0.5
1
1.5
2
2.5
3
MAP3K7 BTRC IκB Phospho
-IκB
Nuclear
p65 
 Aortic  
Arch 
(AA)
 Descending 
Thoracic Aorta 
(DT)
*
*
*
*
R
el
at
iv
e 
pr
ot
ei
n 
 E
xp
re
ss
io
n 
 
Phospho-
IκB
β-actin 
MAP3K7
β-actin 
BTRC
IκB
IκB
LaminB1 
p65
β-actin 
DT AA
B
*
Fig. 7. Endothelial protein expression in swine athero-susceptible AA
andathero-protected DT. (A) Differential endothelial expression of MAP3K7,
βTRC, IκBα, phosphorylated IκBα (n = 5), and nuclear p65 (n = 4; each sample
was pooled from the seven animals) in paired comparisons of AA and DT.
Data represent mean ± SEM. *P < 0.05. (B) Representative Western blots.
13454 | www.pnas.org/cgi/doi/10.1073/pnas.1002120107 Fang et al.
In Situ Hybridization. Expression of miR-10a/b in freshly isolated swine arterial
tissues was determined by a modiﬁed FISH assay that employs LNA probes
and tyramide signal ampliﬁcation, described by Silahtaroglu et al. (28).
Human Whole-Genome Microarray. The complete MIAME-compliant anno-
tated study has been deposited in ArrayExpress (accession number E-CBIL-45),
and annotation and data are available at www.cbil.upenn.edu/RAD. Whole-
genome transcriptomes were determined in control and miR-10a knock-
down cells by whole-human genome 4 × 44K microarrays (Agilent).
Transfection of miR-10a Mimics and Inhibitors.HAECs (Lonza) were transfected
with Homo sapiens miR-10a (hsa-miR-10a) mimics, miRNA mimic negative
controls, hsa-miR-10a inhibitors, or miRNA inhibitor negative controls
(Dharmacon) using Lipofectamine RNAiMAX transfection reagent.
Bioinformatics. Data preprocessing of the microarray studies is described in SI
Methods. Differential expression analysis was performed using Patterns of
Gene Expression (47; PaGE v5.1.6). Genes/miRNAs with less than a 5% false
discovery rate were considered to be differentially expressed. GSEA was used
to identify enriched Gene Ontology (GO) gene sets.
Luciferase Reporter Assay. Three tandem repeats of the miR-10a binding
elements were synthesized and cloned into a pRL-TK vector (Promega). HEK
293 cells were cotransfected with pRL-TK vectors, control pGL3 vectors, and
hsa-miR-10a mimics or miRNA mimic negative controls, followed by dual-
luciferase assays (Promega).
Endothelial Protein Extraction and Western Blots. Protocols are described in
a previous study (9) and in SI Methods. Table S2 lists the primary antibodies
used. Statistical signiﬁcance was assessed for the gene and protein expres-
sion ratios using unpaired two-tailed Student’s t test assuming experimental
samples of unequal variance.
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